background: The number of childhood cancer survivors has dramatically increased and consequently, an increasing number of survivors may now wish to conceive. Recently, several studies have described that previous treatment with abdominal radiotherapy may increase the risk of adverse pregnancy outcome. results: Data were available on 40 survivors and 9031 controls. Median age at diagnosis was 6.9 years (range 0.1 -16.8 years). The median interval between diagnosis and date of delivery was 21.6 years (range 7.4 -36.1 years). In the whole cohort, pregnancy outcome was not different between survivors and controls. However, survivors treated with abdominal radiotherapy delivered preterm and had post-partum haemorrhage (mean gestational age in survivors ¼ 34.9 versus 39.2 weeks in controls, P ¼ 0.001; 33% in survivors versus 5% in controls, P ¼ 0.007, respectively). The offspring of survivors had normal birthweight after adjustment for gestational age (mean birthweight in offspring of survivors 2503 versus 1985 g; P ¼ 0.22).
Introduction
As a result of dramatic improvements in survival of childhood cancer, the number of adult women that have received cancer therapy during their childhood or adolescence will increase (Robison et al., 2009) . Consequently, an increasing number of survivors will reach an age at which they wish to have children. Many uneventful pregnancies have been reported in childhood cancer survivors (Borgna-Pignatti et al., 1996; Jackson et al., 1997; Gulati and Van Poznak 1998; Nagarajan and Robison, 2005) . However, previous studies by our group suggested that ovarian reserve was impaired in cancer survivors (van Beek et al., 2007; Lie Fong et al., 2008 ). In accordance, recent studies have proposed that these women may encounter problems while trying to conceive, which has recently been illustrated in a large report of the Childhood Cancer Survivor Study (Green et al., 2009a, b) . Moreover, an increased risk of miscarriage, preterm delivery and offspring with low birthweight has been recognized as a serious problem in at least subsets of cancer survivors. Hence, studies on pregnancy outcome have shown conflicting results (Sanders et al., 1996; Bath et al., 1999; Salooja et al., 2001; Green et al., 2002a; Kalapurakal et al., 2004; Nagarajan and Robison, 2005; Robison et al., 2005; Battaglia et al., 2006; Signorello et al., 2006; Magelssen et al., 2008; Winther et al., 2008) .
The availability of information on pregnancy outcome in childhood cancer survivors may be biased; reporting on adverse pregnancy outcome may be more challenging than describing successful pregnancies. In addition, so far, results were based on small series of survivors and never compared with population-based control settings (Gulati and Van Poznak, 1998) .
Recent studies on pregnancy outcome in childhood cancer survivors have recruited healthy siblings of these survivors as controls (Sanders et al., 1996; Green et al., 2002a; Kalapurakal et al., 2004; Robison et al., 2005; Signorello et al., 2006) . In the control group of healthy siblings, the number of unsuccessful pregnancy outcomes may be lower due to recall bias. Consequently, the risk of unfavourable outcome in survivors may seem higher than in their healthy sibling controls. In addition, most studies on pregnancy outcome in female cancer survivors have focused mainly on neonatal outcome, such as stillbirth, birthweight and congenital malformations (Sanders et al., 1996; Chiarelli et al., 1999; Green et al., 2002b; Signorello et al., 2006) .
To our knowledge, the current study is the first to describe pregnancy outcome in a single centre cohort of female childhood cancer survivors compared with outcome parameters of a nationwide perinatal database.
Materials and Methods

Subjects
Childhood cancer survivors from the Sophia Children's Hospital in Rotterdam were included, if they had a singleton live birth between January 2000 and December 2005. At inclusion, they were at least 18 years old and at least 5 years after discontinuation of cancer treatment. Participants were recruited at the out-patient clinic for follow-up of long-term effects of childhood cancer treatment. Thirty-five women had participated in a previous study by our group (Lie Fong et al., 2009) . Details on disease and cancer treatment were recorded, including type and cumulative doses of chemotherapy, as well as site, field and cumulative dose of radiotherapy and if applicable, type of surgery. In addition, data on pregnancy outcome, delivery and possible complications during pregnancy or during delivery were collected by extensive history taking. Moreover, these self-reported data were completed by and checked with data retrieved from the national registry of perinatal data, the Netherlands Perinatal Registry (http://www.perinatreg.nl/home_english). This registry contained data on all pregnancies, deliveries and neonatal outcome in the Netherlands between January 2000 and December 2005 and had been provided by medical professionals, i.e. midwives, obstetricians and paediatricians, who were responsible for the women during pregnancy, delivery, birth and the post-natal period.
Control subjects were selected from the Netherlands Perinatal Registry, after matching with survivors by parity, year of birth and month and year of delivery. Hence, all women in the Netherlands who had a singleton live birth between January 2000 and December 2005 were possible control subjects.
This study was approved by the local medical ethics review board and written informed consent was obtained from each participant.
Outcome parameters
Maternal outcome parameters were the highest diastolic blood pressure measured during pregnancy and the prevalence of pre-eclampsia. In offspring gestational age, birthweight, Apgar score, gender and the percentage of congenital malformations were analyzed. Outcome parameters after delivery were post-partum haemorrhage and the prevalence of a manual removal of placenta.
Pregnancy-induced hypertension was defined by diastolic blood pressure .90 mmHg Preterm birth was defined as duration of pregnancy less than 37 weeks. Post-partum haemorrhage was defined as more than 1 l blood loss within 24 h after the delivery. In the national registry, birthweight was reported in grams and length of gestation in weeks. Apgar scores were only available for the assessment carried out 5 min after birth.
Statistical analysis
Outcome parameters were compared between controls and survivors using Students t-test for continuous variables or x 2 test for categorical variables. A univariate analysis of covariance (ANOVA) was performed to calculate differences between subgroups and controls. We expected that besides diagnosis, the type of treatment might also be predictive of pregnancy outcome. Therefore, outcome parameters were compared between groups allocated according to diagnosis and controls, and between groups based on type of treatment and controls. Consequently, in the analysis, parameters in the following groups were compared: childhood acute lymphoblastic leukaemia/non-Hodgkin lymphoma (ALL/NHL) versus controls (other groups allocated according to diagnosis were too small for comparison, see Results), survivors treated with radiotherapy to the abdomen versus controls, and survivors treated with chemotherapy only versus controls (survivors treated with surgery only were omitted from the analysis, since this group was too small, see Results). In the ANOVA calculating differences in birthweight, data were adjusted for gestational age.
Correlations were calculated between the duration of pregnancy and the total dose of radiation with a bivariate correlation. Age at diagnosis was correlated with the length of gestation, using a partial correlation after adjustment for parity. Characteristics in survivors were presented as median and range. Since the group of controls was very large, results of the comparisons between survivors and controls were presented as mean and SD. A P-value for two-sided tests ,0.05 indicates statistical significance. Because of the large sample size of the perinatal registry, these data were provided in SAS/Stat software version 9.0 (SAS Institute Inc., Cary, NC, USA). Statistical analysis on differences between survivors and controls was therefore performed in SAS/Stat. Analyses within the group of childhood cancer survivors only were performed with Statistical package for Social Sciences version 15.0 (SPSS Inc., Chicago, IL, USA).
Results
Subjects
From the total cohort of 238 female survivors, six women were lost to follow-up. Of the 232 eligible women, five had died during follow-up and six refused participation. In addition, three women had emigrated and three women were severely disabled, and were not able to visit the out-patient clinic. Finally, in the studied cohort of 215 childhood cancer survivors, 64 women had been pregnant, of whom 40 (n ¼ 40/215; 18.6%) had a singleton live birth between 1 January 2000 and 31 December 2005. At study inclusion, the survivors included in the analysis (n ¼ 40) were significantly older than childhood cancer survivors that had not been pregnant (median age 29.9 versus 23.8 years, respectively; P , 0.001). However, diagnoses and treatment were similar in the 40 women included and the excluded survivors (P ¼ 0.44).
At diagnosis, the 40 study subjects were 6.9 years old (median; range 0.1-16.8 years) and their median age at time of delivery was 29.7 years (range 21.4 -36.8 years). The median interval between diagnosis and date of delivery was 21.6 years (range 7.4-36.1 yeas) and the median interval between end of therapy and date of delivery was 20.2 years (range 6.9 -32.5 years). Most women were primiparous (n ¼ 28/40; 70%); 20% (n ¼ 8/40) had been pregnant for the second time, three women (7.5%) had been pregnant three times and one survivor (2.5%) had five pregnancies before study inclusion.
Pregnancy outcome in childhood cancer survivors
The 40 women were treated for different malignancies; the largest group had survived ALL or NHL (the 'ALL&NHL group'; Table I ). Survivors had been treated according to standard national and international treatment protocols, containing a variety of multiple drug combinations. Therefore, it was not feasible to evaluate the effect of each type of chemotherapy on pregnancy outcome parameters. Sixteen women had received radiotherapy, six of whom had received radiotherapy to the abdomen (n ¼ 1) or flank (n ¼ 4) and in one patient data on the exact size of the radiation field could not be retrieved. The six survivors who had received radiotherapy to the abdomen were referred to as 'group treated with abdominal radiotherapy' and at diagnosis their median age was 1.1 years (range 0.3-5.2 years). The median total cumulative dose of radiation given to the 16 irradiated survivors was 25.0 Gray (Gy) (2.0 -40.0 Gy). This dose was 19.8 Gy (2.0 -26.5 Gy) in the group treated with abdominal radiotherapy. The three women who had been treated with surgery only, were excluded from analysis. Table I shows details of diagnosis and treatment. Data on 9.031 control subjects could be retrieved from the nationwide perinatal database.
Pregnancy outcome
There were no differences in maternal outcome parameters between the total cohort of survivors and controls after matching by parity, year of birth, month and year of delivery. Neonatal outcome parameters, such as gender, gestational age, Apgar score and the percentage of congenital abnormalities, were not different in children born to survivors compared with those born to healthy controls (Table II) .
In survivors of the 'ALL&NHL group' (n ¼ 17), neither neonatal nor maternal outcome parameters were different from those in controls (data shown in the Supplementary Data, Table) . Other groups based on diagnosis were considered too small for separate analysis (Table I ). In the group treated with abdominal radiotherapy (n ¼ 6), the highest diastolic pressure and the percentage of spontaneous vaginal deliveries were similar to that of controls (P ¼ 0.80; P ¼ 0.63) (Table II) . However, the number of preterm deliveries was higher in survivors who received abdominal radiotherapy than in controls (mean term of delivery in survivors 34.9 versus 39.2 weeks in controls, P ¼ 0.001) (Table II) . Consequently, birthweight in offspring of survivors was lower than children of control subjects (mean birthweight 2503 versus 3271 g, respectively; P ¼ 0.02). After adjustment for gestational age, birthweight was similar in children born to survivors and those born to control subjects (mean birthweight 2503 versus 1985 g, respectively; P ¼ 0.22) (Fig. 1) (Kloosterman, 1969) . Birthweight was lower than the 50th percentile in five out of six children born to women who received abdominal radiotherapy (Fig. 1) . Apgar score 5 min after birth was similar in offspring of survivors treated with abdominal radiotherapy and offspring of controls (P ¼ 0.26) ( Table II) . A significantly larger proportion of survivors had a post-partum haemorrhage than controls (33 versus 5%, respectively; P ¼ 0.007). The comparison of the number of these six survivors and controls needing a manual removal of the placenta did not reach statistical significance (17 versus 3%, respectively; P ¼ 0.08). In all women treated with radiotherapy, the total dose of radiation was correlated with the length of gestation (r ¼ 0.67; P ¼ 0.004). However, the dose of radiation administered to the abdomen was not correlated with the term of birth (r ¼ 0.46; P ¼ 0.35) (data not shown).
Twenty-one women had been treated with chemotherapy only. Their median age at diagnosis was 9.9 years (range 0.1-15.6 years). No significant differences in maternal or neonatal variables were observed between these survivors and controls (data shown in the Supplementary Data, Table) .
Age at diagnosis was positively correlated with the duration of pregnancy (r ¼ 0.48, P ¼ 0.006) in the whole cohort. However, this correlation no longer reached statistical significance after exclusion of the six survivors treated with abdominal radiotherapy (r ¼ 20.20; P ¼ 0.34). Since these six women had been treated at the median age of 1.1 years (range 0.3-5.2 years), age at diagnosis and pregnancy duration were not significantly correlated (r ¼ 0.59, P ¼ 0.30) in the group treated with abdominal radiotherapy. 
Discussion
To our knowledge, this is the first retrospective analysis on pregnancy outcome in a single centre cohort of childhood cancer survivors, which compares these data with healthy age-matched controls recruited from a nationwide database. In the total cohort of childhood cancer survivors, pregnancy outcome was not different from that in the general population. However, the current study shows that in the group of survivors who had undergone abdominal irradiation, the frequency of preterm deliveries was higher than in controls, as previously reported (Critchley et al., 1992; Sanders et al., 1996; Salooja et al., 2001; Green et al., 2002a; Signorello et al., 2006) . Besides that, the frequency of post-partum haemorrhage was also higher than in controls: although our findings were based on data of only six survivors, this has not been reported so far in childhood cancer survivors. Most of these women received radiation to the flank and none of them was irradiated to the pelvis. In addition, these six women had been treated at a very young age, when the uterus is small. Hence, it may not be expected that radiotherapy to the abdomen had caused the adverse pregnancy outcome. Indeed, earlier studies showed that abdominal irradiation of at least 20 Gy caused irreversible damage to the Data are presented as number, n (%) or mean (SD). CCS, childhood cancer survivors.
08. *P ¼ 0.02 versus control (but NS when data adjusted for gestational age). uterine musculature and blood flow (Critchley et al., 1992) . Although scatter radiation to the uterus could not be prevented, it is not plausible that the different radiotherapy regimens in our six survivors have resulted in compromised uterine musculature. Possibly, chemotherapy might have damaged uterine structures, resulting in smaller uterine volume and hence, restricting uterine distensibility (Battaglia et al., 2006) . This finding will need to be confirmed in a larger prospective study sample.
Impaired vascular adaptation to placentation has been associated with pregnancy-induced hypertension, pre-eclampsia and intrauterine growth restriction (Roberts and Cooper, 2001; Sibai et al., 2005) . Although the severity of pre-eclampsia and its maternal complications may vary considerably, women with pre-eclampsia are at risk of preterm birth and children small for gestational age (Hauth et al., 2000) . We therefore speculated that women previously treated with abdominal radiotherapy may also encounter vascular-related problems during pregnancy. However, surprisingly, there were no significant differences in diastolic blood pressure between survivors and controls. To date, no studies have addressed possible hypertension related problems during pregnancy in long-term childhood cancer survivors (Salooja et al., 2001) .
It has been assumed that prior to menarche, blood flow through the internal genital system is lower than during puberty and the reproductive lifespan (Laursen et al., 1996) . Consequently, it could be hypothesized that cancer treatment may cause less damage when administered prior to menarche. However, in our results, age at diagnosis did not influence the term of delivery. Since none of our six survivors had reached menarche at time of abdominal irradiation, their pre-menarcheal stage did not seem to protect against adverse effects of cancer treatment regarding uterine distensibility and contractility. These findings confirm that chemotherapy and radiotherapy administered in children may cause permanent damage to the uterine musculature, independent of menarcheal stage at treatment.
In contrast, in girls previously treated with total body irradiation it was shown that young age at treatment was correlated with smaller uterine volume, assessed at young adulthood (Bath et al., 1999) . In that study, controls were childhood cancer survivors treated with chemotherapy, but without radiotherapy to the uterus (Bath et al., 1999) . Another recent study showed that adult childhood cancer survivors with regular menstrual cycles had lower uterine blood flow and smaller uterine volume than age-matched healthy controls (Battaglia et al., 2006) . This illustrates the importance of the design of the current study, in which healthy age-matched women were used as controls. In addition, findings of the aforementioned studies suggest that a smaller uterine volume may be expected in our survivors previously treated with radiotherapy to the uterus. Unfortunately, ultrasound data on uterine volume were not available, neither in our survivors nor in controls, but the higher frequency of preterm deliveries may reflect the restricted uterine volume in irradiated women in our study group.
In the current study, data from the nationwide registry, which were recorded by medical professionals, were used as control data. Consequently, recall bias that is characteristic of self-report studies was avoided (Green et al., 2009b; Leisenring et al., 2009; Reulen et al., 2009) . However, in the Netherlands Perinatal Registry, only births between 2000 and 2005 were available for analysis and hence, matching for parity, year of birth, month and year of delivery resulted in a study group of only 40 survivors. So, despite the solid control cohort, only a small sample of survivors was included. In addition, the national registry did not document ethnicity. Therefore, our cases and controls could not be matched for this parameter, in contrast to previous siblings-control studies (Green et al., 2002b , Figure 1 Birthweight (in grams) in offspring of childhood cancer survivors in population-based birthweight curves per gestational age (in weeks) (Kloosterman 1969) . Dashed dotted line, 2.3th and 97.7th percentile; dotted line, 10th and 90th percentile; continuous line, 50th percentile; filled triangle, offspring of survivors not treated with abdominal radiotherapy (n ¼ 34); filled circle, offspring of survivors treated with abdominal radiotherapy (n ¼ 6).
2009b; Getahun et al., 2005; Robison et al., 2005; Signorello et al., 2006; Balchin et al., 2007; Leisenring et al., 2009) . Similarly, neither BMI nor smoking habits were registered in the Dutch nationwide database.
Offspring of our survivors treated with abdominal radiotherapy had a birthweight appropriate for gestational age after adjustment for gestational age. Similarly, in another recent study, women treated with flank irradiation delivered prematurely and consequently, their children had lower birthweight (Green et al., 2002a (Green et al., , 2009b . It was concluded that childhood cancer survivors were at risk of children with low birthweight although that it was not clear whether birthweight had been adjusted for gestational age in that study (Green et al., 2002a (Green et al., , 2009b . Another study reported an increased risk of having children small for gestational age in female survivors previously treated with abdominal irradiation. However, they compared pregnancy outcome in survivors treated with abdominal radiotherapy to those treated without abdominal radiotherapy, without comparison to offspring of healthy controls (Signorello et al., 2006; Green et al., 2009b) . In our study, low birthweight seems to be attributable to preterm birth. Nevertheless, the majority of these children had a birthweight lower than the 50th percentile of offspring of healthy women. Hence, these findings will need to be confirmed in a larger cohort and should be compared with a large cohort of age-matched healthy controls.
On the basis of our results, health care-providers should be aware of the increased frequency of possible complications during delivery and the post-partum period in survivors treated with abdominal radiotherapy during childhood. Therefore, perinatal care should be optimized, specifically in female childhood cancer survivors who received abdominal radiotherapy. Consequently, home birth should be discouraged in this particular group of childhood cancer survivors.
In conclusion, in our whole cohort of survivors, pregnancy outcome was similar to that in healthy controls. As described in earlier studies, women treated with abdominal radiotherapy delivered preterm. In addition, we were the first to describe an increased frequency of postpartum haemorrhage in female childhood cancer survivors irradiated to the abdomen, which stresses the importance of delivery in an inpatient setting in these women.
